A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

In this comprehensive online program experts discuss how to select optimal therapies for patients with B-cell lymphomas. Get up to date with expert commentaries an on-demand webcast and slides from a dynamic CCO symposium at ASH 2021 downloadable resources on 10 key agent classes and an audio podcast.

Share

Program Content

No activities added yet

Activities

Sequencing FL Therapy
How I Sequence Therapy for Patients With Follicular Lymphoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 01, 2021

Expires: October 31, 2022

Treating MCL
How I Treat Patients With Mantle Cell Lymphoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2021

Expires: November 11, 2022

Sequencing BTKi in MZL
Sequencing BTK Inhibitors in Treatment of Marginal Zone Lymphomas
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2021

Expires: November 01, 2022

Treating DLBCL
How I Sequence Treatment for Patients With Diffuse Large B-Cell Lymphoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2021

Expires: November 30, 2022

Treating EBV+ PTLD
How I Treat Patients With EBV-Associated Posttransplant Lymphoproliferative Disease
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2021

Expires: December 05, 2022

Activities

Advances in FL
New Advances in Follicular Lymphoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2021

Expires: December 14, 2022

Advances in MZL and MCL
What’s New in Marginal Zone Lymphoma and Mantle Cell Lymphoma?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2021

Expires: December 15, 2022

Advances in DLBCL
New Advances in Diffuse Large B-Cell Lymphoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2021

Expires: December 15, 2022

EBV-Associated PTLD
Novel Approaches to the Treatment of EBV-Associated Post-Transplant Lymphoproliferative Disorders
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2021

Expires: December 15, 2022

<i>EP</i>: Advances in B-Cell Lymphomas
ExpressPoints: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 04, 2022

Activities

IMiDs and ICIs for B-Cell Lymphomas
Immunomodulatory Agents and Immune Checkpoint Inhibitors in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 27, 2021

Expires: December 26, 2022

XPO1 Inhibitors for B-Cell Lymphomas
XPO1 and Nuclear Export Inhibitors in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 28, 2021

Expires: December 27, 2022

BCL-2 in B-Cell Lymphomas
BCL-2 Targeted Therapy in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2021

Expires: December 09, 2022

PI3Ki in B-Cell Lymphomas
PI3K Inhibitors in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2021

Expires: December 12, 2022

CAR T-cells for B-Cell Lymphomas
CAR T-cell Therapy in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2021

Expires: December 09, 2022

Epigenetic Therapies in B-Cell Lymphomas
Epigenetic Therapies in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2021

Expires: December 12, 2022

Ab-Based Tx in B-cell Lymphomas
Antibody-Based Therapies for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 17, 2021

Expires: December 16, 2022

Bispecific Abs in B-Cell Lymphomas
Bispecific Antibodies in B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 27, 2021

Expires: December 26, 2022

BTKi for B-Cell Lymphomas
BTK Inhibitors for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 04, 2022

Expires: January 03, 2023

ADCs for B-Cell Lymphomas
Antibody–Drug Conjugates for B-Cell Lymphomas: A Summary Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2021

Expires: December 28, 2022

Activities

Advances in B-Cell Lymphomas
Advances in B-Cell Lymphomas: Understanding Current Treatment Approaches
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2022

Expires: February 24, 2023

<i>Podcast Pearls</i>: B Cell Lymphomas
Podcast Pearls: Advances Across B Cell Lymphomas
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2022

Expires: February 24, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Atara Biotherapeutics

Bayer Healthcare Pharma

BeiGene, Ltd.

Epizyme

Genentech, a member of the Roche Group

Genmab US, Inc.

Incyte Corporation

Karyopharm Therapeutics

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc